Cardiol Therapeutics (CRDL) Change in Inventory (2020)

Cardiol Therapeutics' (CRDL) quarterly Change in Inventory came in at $711198.5 in Q4 2020.

Cardiol Therapeutics (CRDL) Change in Inventory (2020) Analysis & Trends

Cardiol Therapeutics (CRDL) has 1 years of Change in Inventory data on file, last reported at $711198.5 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	-59.00 Mn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	23.00 Mn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	-209.58 Mn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	17.70 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	99.50 Mn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	6.50 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Cardiol Therapeutics	215.50 Mn	196.65 Mn	-	-

Download Data

Date	Value
Dec 31, 2020	711,198.51
Dec 31, 2020	711,198.51